NEW HAVEN, Conn, Sept. 8, 2014 — Melinta Therapeutics today provided an update on the Company’s innovative ESKAPE Pathogen Program. The ESKAPE Pathogen Program leverages Melinta’s knowledge and experience in crystallography and computational chemistry to generate new classes of antibiotics and new molecules within those classes to treat the extensively drug resistant (XDR) and multi-drug resistant (MDR) “superbug” bacteria, also known as the ESKAPE pathogens. 757 more words
Tags » Superbug
Wow, so its been a good few weeks since my last post.
So on to the subject of antibiotics. It seems that at least once a month, there is a new story in the news and tabloids about “superbugs” (basically bacteria that are resistant to antibiotics such as MRSA) claiming that we are at the end the the antibiotic era, stating that the increasing levels of antibiotic resistance are pushing us back to a time when even the smallest cut could kill you: 453 more words
By Saundra Young
(CNN) — The rise in antibiotic-resistant bacteria could lead to a future full of untreatable infections, experts have warned us for years. 583 more words